inhaled insulin

Why MannKind Stock Crushed it Monday
Why MannKind Stock Crushed it Monday
Motley Fool
MannKind
ADA
diabetes
insulin
Afrezza
inhaled insulin
Flag link:
Why MannKind Is Up Big Today
Why MannKind Is Up Big Today
Motley Fool
MannKind
inhaled insulin
Afrezza
Flag link:
Dance Biopharm raises $24m for inhaled insulin device
Dance Biopharm raises $24m for inhaled insulin device
Drug Delivery Business News
Dance Biopharm
inhaled insulin
diabetes
Flag link:
FDA approves new label language for Afrezza
FDA approves new label language for Afrezza
Greenwich Citizen, CT
FDA
labeling
Afrezza
inhaled insulin
MannKind
diabetes
Flag link:
Why MannKind Stock Started October With a Bang
Why MannKind Stock Started October With a Bang
Motley Fool
MannKind
inhaled insulin
Afrezza
diabetes
Flag link:
MannKind - Afrezza Scripts Finish August Flat
MannKind - Afrezza Scripts Finish August Flat
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind combines inhaled insulin with One Drop’s digital diabetes tech
MannKind combines inhaled insulin with One Drop’s digital diabetes tech
Drug Delivery Business News
MannKind
inhaled insulin
One Drop
Afrezza
Flag link:
MannKind: Afrezza Television Ad Debuts; What Investors Need To Know
MannKind: Afrezza Television Ad Debuts; What Investors Need To Know
Seeking Alpha
MannKind
Afrezza
drug ads
diabetes
investors
inhaled insulin
Flag link:
MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump
MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump
Seeking Alpha
Afrezza
MannKind
diabetes
inhaled insulin
Flag link:
MannKind: Afrezza Sales See Best Result In More Than A Year
MannKind: Afrezza Sales See Best Result In More Than A Year
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind Scripts Not Helping Cash Situation
MannKind Scripts Not Helping Cash Situation
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind inks deal to bring inhaled insulin to Brazil
MannKind inks deal to bring inhaled insulin to Brazil
Drug Delivery Business News
MannKind
Brazil
diabetes
inhaled insulin
Afrezza
Flag link:
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
Drug Delivery Business News
One Drop
MannKind
inhaled insulin
diabetes
devices
Afrezza
Flag link:
MannKind: Afrezza Sales Remain Low As Q1 Comes To A Close
MannKind: Afrezza Sales Remain Low As Q1 Comes To A Close
Seeking Alpha
MannKind
Afrezza
inhaled insulin
diabetes
Flag link:
Could MannKind Corporation's Marketing Blitz Pay Off?
Could MannKind Corporation's Marketing Blitz Pay Off?
Motley Fool
MannKind
Afrezza
diabetes
inhaled insulin
Sanofi
drug ads
Flag link:
Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February
Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February
Motley Fool
MannKind
diabetes
inhaled insulin
Afrezza
Flag link:
Can MannKind Be Saved?
Can MannKind Be Saved?
Barron's
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind Attempts to Revive Afrezza Sales
MannKind Attempts to Revive Afrezza Sales
Investopedia
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
Afrezza Sales Still Low As MannKind Prepares For Investor Update
Afrezza Sales Still Low As MannKind Prepares For Investor Update
Seeking Alpha
Afrezza
MannKind
diabetes
inhaled insulin
Flag link:
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?
Seeking Alpha
MannKind
Afrezza
diabetes
drug reps
inhaled insulin
Flag link:

Pages